Blog
5-Amino-1MQ: what a mouse study can tell us about metabolism
The useful question is how NNMT inhibition interacts with dietary conditions. An animal result does not establish a safe human intervention.
Evidence discussed: Animal study.
What the researchers studied
Researchers examined an inhibitor of nicotinamide N-methyltransferase in mice with diet-induced obesity. Combining 5-amino-1-methylquinolinium with a lower-fat diet produced larger changes in weight and fat mass than the diet change alone. The study also examined the gut microbiome. [1]
How to interpret the result
This was not a trial of weight loss in people. Diet and drug exposure were both part of the design, so attributing every change to the compound would misrepresent the comparison. Microbiome differences do not establish causation.
What readers can take from it
The useful question is how NNMT inhibition interacts with dietary conditions. An animal result does not establish a safe human intervention.
This original editorial summary provides no diagnosis, dosing or treatment advice. The study did not test or certify a PeptiKing product.
Source
[1] Reduced-calorie diet and NNMT inhibition in obese mice (2022). PMID: 35013352. Based on the PubMed-indexed abstract and record; full-text methods were not independently reviewed.